Newsmakers

Live Sports Are Back on fuboTV (OTC: FUBO)

As the world continues to be impacted by the COVID-19 pandemic, there are positive signs life is returning to normal – including the return of live sports. FaceBank Group, Inc. (d/b/a fuboTV) (OTCQB: FUBO) kicks […]

No Picture
Trading Ideas

3 Big Dividend Stocks Yielding Over 7%; JPMorgan Says ‘Buy’

With unemployment rising to 15%, and the grim corporate earnings seasons wrapping up, investors may struggle to keep up the relatively buoyant mood that has boosted markets in recent weeks. They may find some support from the Federal Reserve, where Chairman Jerome Powell this week urged Congress and the White House to agree on additional stimulus packages. The Fed has already cut rates down to 0 to 25 basis points; they have no further ammunition, so if more help is to come, it will need to come on the spending side. Urging action, Powell said that an economic recovery “could …read more […]

Healthcare

CytoDyn (OTC: CYDY) to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19

VANCOUVER, Washington, May 15, 2020– CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it is […]

No Picture
Trading Ideas

Sarepta Gains After Pfizer DMD Gene Therapy Data Fall Short

(Bloomberg) — Pfizer Inc.’s experimental gene therapy for Duchenne muscular dystrophy helped boys with the deadly disease, but failed to match benefits previously shown by competitor Sarepta Therapeutics Inc.All nine of the boys, ages 6 to 12, in the early-stage trial started to produce a key protein called dystrophin after receiving the one-time treatment. While patients with DMD don’t normally make any of the protein needed for muscles to work properly, three boys on a higher dose of the gene therapy produced about 52% of normal levels a year after treatment, Pfizer said in a statement.One boy on the higher …read more […]

No Picture
Trading Ideas

Taiwan's TSMC keeps eye on China with $12 billion U.S. plant

In a race to position itself in the latest trade battle between the United States and China, Taiwan Semiconductor Manufacturing Co Ltd made it just under the wire. The world’s biggest contract chipmaker unveiled plans for a $12 billion plant in Arizona on Friday just hours before Washington outlined a proposal to amend tech export rules that could restrict TSMC’s sales to China’s Huawei. A U.S. Commerce Department official said TSMC’s decision to locate the plant in the United States generated “good will” at the department, the drafter of the law that would require TSMC and others to …read more […]